Learn more about Prof. Michael King and his group. The King Lab utilizes nanostructured surfaces and lipid nanoparticles to study the mechanobiology of circulating cancer and immune cells, and for drug delivery strategies to target metastatic cells in the blood and lymphatic circulation.